Regenxbio Inc. (RGNX) PT Lowered to $25 at RBC Capital

April 3, 2025 9:08 AM EDT
Get Alerts RGNX Hot Sheet
Price: $10.66 -2.29%

Rating Summary:
    14 Buy, 4 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
RBC Capital analyst Luca Issi lowered the price target on Regenxbio Inc. (NASDAQ: RGNX) to $25.00 (from $30.00) while maintaining a Outperform rating.

You May Also Be Interested In





Related Categories

Analyst PT Change